Visalytics
Visalytics
approved EB-2 (NIW)

Founder And Principal Consultant

Biomedical Science · Turkey · 2023-08-24

Processing Time
2 days
Decision Date
2023-08-24
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research on developing cutting-edge nanotherapeutic and nanotheranostic systems, as well as toxicology assays. This work focuses on improving cancer diagnosis and treatment while evaluating and reducing the toxicity of biomedical materials and devices.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses cancer, which caused 10 million deaths in 2020, and aims to decrease financial burdens and improve U.S. population health.

2 Well-positioned to Advance the Endeavor Met

The petitioner has a strong track record including 12 publications, 259 citations, and 11 peer reviews.

3 Waiver of Job Offer and Labor Certification Met

On balance, the petitioner's contributions to effective cancer therapies benefit the U.S. even if other qualified workers are available.

Why This Petition Was Approved

The petition was approved based on the petitioner's 12 peer-reviewed journal articles (8 first-authored) and 259 citations. Additional evidence included 11 completed peer reviews and prior funding from the Scientific and Technological Research Council of Türkiye (TÜBİTAK), satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Judging Experience
Original Contributions

Similar Cases

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
162 days 2025-04-17
The petitioner proposes to continue his research in molecular biomedicine, specifically focusing on the development of nanoparticle-based delivery systems. His work aims to improve targeted cancer therapies, including chemotherapy, immunotherapy, and tumor thermal therapy, to enhance therapeutic efficacy while reducing side effects. The intended impact is to advance cancer care and oncology breakthroughs within the U.S. healthcare system.
View Case

Postdoctoral Researcher

Biotechnology · Bangladesh

WeGreened EB-2 (NIW) approved
Massachusetts 309 days 2025-04-01
The petitioner proposes to continue research in the United States focused on synthesizing tumor-targeted nanocarriers for RNA therapeutic delivery and improving mRNA purification systems. This work aims to develop cost-effective and scalable solutions for cancer vaccines and RNA-based therapies. The endeavor is designed to address critical challenges in cancer therapy and vaccine manufacturing.
View Case

Research Fellow

Biotechnology · India

WeGreened EB-2 (NIW) approved
Florida 48 days 2025-09-04
The petitioner proposes to develop precision oncology tools by integrating nanotechnology, immunology, and computational methods to engineer next-generation cancer therapies. His work specifically focuses on designing personalized, neoantigen-based nano vaccines and SMART-lipid nanoparticles to improve immune system responsiveness and overcome tumor immune evasion.
View Case

Scientist

Biotechnology · Nepal

WeGreened EB-2 (NIW) approved
Arkansas 14 days 2025-02-20
The petitioner proposes to synthesize novel engineered nanoplatforms for therapeutic applications and develop non-cell culture-based efficacy determination methods for targeting therapeutic nanomaterials. The work aims to create cancer treatments with high specificity to improve treatment effectiveness while reducing off-target effects.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Turkey

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-08-24.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 2 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Turkey All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist